These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2188 related items for PubMed ID: 8822197

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
    Hu X, Zhang X, Zhong Q, Fisher AB, Bryington M, Zuckerman KS.
    Oncogene; 2001 Oct 18; 20(47):6840-50. PubMed ID: 11687963
    [Abstract] [Full Text] [Related]

  • 23. Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells.
    Shimizu T, Awai N, Takeda K.
    Oncogene; 2000 Sep 21; 19(40):4640-6. PubMed ID: 11030153
    [Abstract] [Full Text] [Related]

  • 24. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR.
    Nature; 1997 May 22; 387(6631):422-6. PubMed ID: 9163430
    [Abstract] [Full Text] [Related]

  • 25. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE, Xiong Y.
    Cell Growth Differ; 1998 Aug 22; 9(8):595-610. PubMed ID: 9716177
    [Abstract] [Full Text] [Related]

  • 26. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I, Polyak K, Iavarone A, Massagué J.
    Genes Dev; 1995 Aug 01; 9(15):1831-45. PubMed ID: 7649471
    [Abstract] [Full Text] [Related]

  • 27. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
    Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B.
    EMBO J; 1996 Dec 02; 15(23):6595-604. PubMed ID: 8978686
    [Abstract] [Full Text] [Related]

  • 28. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.
    J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912
    [Abstract] [Full Text] [Related]

  • 29. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1).
    Wang G, Miskimins R, Miskimins WK.
    Exp Cell Res; 2000 Jan 10; 254(1):64-71. PubMed ID: 10623466
    [Abstract] [Full Text] [Related]

  • 30. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.
    Van Dross R, Yao S, Asad S, Westlake G, Mays DJ, Barquero L, Duell S, Pietenpol JA, Browning PJ.
    J Natl Cancer Inst; 2005 May 04; 97(9):656-66. PubMed ID: 15870436
    [Abstract] [Full Text] [Related]

  • 31. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C, Chattopadhyay A, Parkhurst C, Yang E.
    Oncogene; 2002 Nov 07; 21(51):7765-75. PubMed ID: 12420213
    [Abstract] [Full Text] [Related]

  • 32. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F, Depoortere F, Bartek J, Ledent C, Parmentier M, Dumont JE.
    Oncogene; 1998 Aug 06; 17(5):631-41. PubMed ID: 9704929
    [Abstract] [Full Text] [Related]

  • 33. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y.
    J Cell Biochem; 1999 Sep 01; 74(3):486-98. PubMed ID: 10412049
    [Abstract] [Full Text] [Related]

  • 34. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.
    Blood; 2000 Oct 15; 96(8):2746-54. PubMed ID: 11023508
    [Abstract] [Full Text] [Related]

  • 35. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K, Järvinen K, Paasinen-Sohns A, Hölttä E.
    Cancer Res; 2000 Sep 15; 60(18):5244-53. PubMed ID: 11016654
    [Abstract] [Full Text] [Related]

  • 36. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells.
    Carstens CP, Krämer A, Fahl WE.
    Exp Cell Res; 1996 Nov 25; 229(1):86-92. PubMed ID: 8940252
    [Abstract] [Full Text] [Related]

  • 37. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A, Washington Parks R, Rivadeneira E, Franchini G.
    Oncogene; 1999 Apr 15; 18(15):2441-50. PubMed ID: 10229195
    [Abstract] [Full Text] [Related]

  • 38. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
    Braun K, Hölzl G, Soucek T, Geisen C, Möröy T, Hengstschläger M.
    Oncogene; 1998 Oct 29; 17(17):2259-69. PubMed ID: 9811456
    [Abstract] [Full Text] [Related]

  • 39. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.
    Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N.
    Nature; 1997 Nov 13; 390(6656):184-7. PubMed ID: 9367157
    [Abstract] [Full Text] [Related]

  • 40. Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts.
    Kilbey A, Stephens V, Bartholomew C.
    Cell Growth Differ; 1999 Sep 13; 10(9):601-10. PubMed ID: 10511310
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 110.